PS
BMY icon

Pinney & Scofield’s Bristol-Myers Squibb BMY Stock Holding History

Pinney & Scofield’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9K Hold
450
– – 0.01% 149
2026
Q1 		$27.3K Hold
450
– – 0.01% 145
2025
Q4 		$24.3K Hold
450
– – 0.01% 143
2025
Q3 		$20.3K Hold
450
– – 0.01% 147
2025
Q2 		$20.8K Hold
450
– – 0.01% 147
2025
Q1 		$27.4K Hold
450
– – 0.02% 124
2024
Q4 		$25.5K Buy
+450
New +$25.1K 0.02% 132

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pinney & Scofield's BMY Position: Q2 2026 in Review

Pinney & Scofield held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 450 shares worth $25.9K. The position accounts for 0.01% of the portfolio, ranked #149.

Pinney & Scofield first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.4K in Q1 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Pinney & Scofield held 450 shares of Bristol-Myers Squibb worth $25.9K as of Q2 2026.
  • Pinney & Scofield left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Pinney & Scofield's portfolio in Q2 2026, its #149 holding.
  • Pinney & Scofield first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Pinney & Scofield's Bristol-Myers Squibb position peaked at $27.4K in Q1 2025.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pinney & Scofield's 13F filing for Q2 2026, filed 7 Aug 2026.